Literature DB >> 18978292

Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma.

C Targhetta1, M G Cabras, E Angelucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18978292     DOI： 10.3324/haematol.13750

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  1 in total

1.  Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era.

Authors:  Davide Bedognetti; Gabriele Zoppoli; Mario Roberto Sertoli; Elisa Zanardi; Pietro Blandini; Lorenzo Uccellini; Francesco Boccardo; Giovanni Battista Andreoli; Riccardo Ghio; Omar Racchi; Manlio Ferrarini; Andrea De Maria
Journal:  Int J Hematol       Date:  2010-02-27       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.